Valued Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.08K Sell
39
-31
-44% -$2.5K ﹤0.01% 570
2026
Q1
$6.11K Buy
70
+18
+35% +$1.72K ﹤0.01% 361
2025
Q4
$5.3K Buy
52
+7
+16% +$680 ﹤0.01% 297
2025
Q3
$4.32K Hold
45
﹤0.01% 304
2025
Q2
$3.96K Buy
45
+11
+32% +$933 ﹤0.01% 313
2025
Q1
$3.08K Sell
34
-7
-17% -$626 ﹤0.01% 366
2024
Q4
$3.3K Buy
41
+7
+21% +$606 ﹤0.01% 353
2024
Q3
$3.08K Buy
34
+11
+48% +$925 ﹤0.01% 332
2024
Q2
$1.83K Sell
23
-8
-26% -$656 ﹤0.01% 375
2024
Q1
$2.72K Sell
31
-45
-59% -$3.84K ﹤0.01% 318
2023
Q4
$6.01K Buy
+76
New +$5.79K 0.01% 178

Other funds holding MDT

Valued Wealth Advisors's MDT Position: Q2 2026 in Review

Valued Wealth Advisors reduced its Medtronic (MDT) stake by 44% in Q2 2026, selling an estimated $2.5K and leaving 39 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Valued Wealth Advisors first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.11K in Q1 2026. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Valued Wealth Advisors held 39 shares of Medtronic worth $3.08K as of Q2 2026.
  • Valued Wealth Advisors sold 31 Medtronic shares in Q2 2026, an estimated $2.5K.
  • Medtronic made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #570 holding.
  • Valued Wealth Advisors first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Valued Wealth Advisors's Medtronic position peaked at $6.11K in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.